Bershad Eric M, Anand Aashish, DeSantis Stacia M, Yang Ming, Tang Rosa A, Calvillo Eusebia, Malkin-Gosdin Leslie, Foroozan Rod, Damani Rahul, Maldonado Nelson, Gupta Pramod, Tan Benedict, Venkatasubba Rao Chethan P, Suarez Jose I, Clark Jonathan B, Sutton Jeffrey P, Donoviel Dorit B
Department of Neurology, Baylor College of Medicine, Houston, Texas, USA; Center for Space Medicine, Baylor College of Medicine, Houston, Texas, USA.
Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
World Neurosurg. 2016 May;89:647-653.e1. doi: 10.1016/j.wneu.2015.11.102. Epub 2015 Dec 25.
Noninvasive intracranial pressure (ICP) measurement would represent a major advance for patients with neurological problems. The Vittamed ICP meter is an ultrasound-based device reported to have high agreement with lumbar puncture cerebrospinal fluid (CSF) pressure measurement. However, previous studies included mostly patients with normal levels of ICP. The purpose of our study was to perform an independent clinical validation study of a transcranial Doppler-based noninvasive ICP meter in patients anticipated to have a wide range of ICP.
In a prospective cross-sectional design, we simultaneously measured ICP with the Vittamed device and the invasive lumbar CSF pressure. The operator of each procedure was blinded to the result of the other method. Data were analyzed using Bland-Altman plots, Pearson correlation coefficients, and receiver operator characteristic curves.
Twenty-four independent paired measurements of Vittamed and lumbar CSF pressure were obtained; with mean absolute difference between paired measures of 4.5 mmHg (standard deviation 3.1). The 95% limits of agreement were -10.5 to +11.0. The systematic bias (mean of paired differences) was negligible at 0.25 mmHg. The sensitivity, specificity, and area under the curve for ICP >20 mmHg were 0.73, 0.77, and 0.71, respectively.
The Vittamed ICP meter had fair agreement with lumbar CSF pressure measurement. The wide limits of agreement would preclude using this version of the device as a stand-alone method for ICP determination, but may be useful if combined with other ICP screening methods. Ongoing improvements to the Vittamed hardware and software may lead to improvements in accuracy and clinical utility of this device.
无创颅内压(ICP)测量对神经系统疾病患者而言将是一项重大进展。Vittamed ICP测量仪是一种基于超声的设备,据报道其与腰椎穿刺脑脊液(CSF)压力测量具有高度一致性。然而,先前的研究主要纳入了颅内压水平正常的患者。我们研究的目的是对一种基于经颅多普勒的无创ICP测量仪在预计颅内压范围广泛的患者中进行独立的临床验证研究。
采用前瞻性横断面设计,我们同时使用Vittamed设备和有创腰椎脑脊液压力测量法测量颅内压。每个测量过程的操作人员对另一种方法的结果均不知情。使用Bland-Altman图、Pearson相关系数和受试者操作特征曲线对数据进行分析。
获得了24对Vittamed测量值与腰椎脑脊液压力的独立配对测量数据;配对测量值之间的平均绝对差值为4.5 mmHg(标准差3.1)。95%一致性界限为-10.5至+11.0。系统偏差(配对差值的均值)在0.25 mmHg时可忽略不计。对于颅内压>20 mmHg,其敏感性、特异性和曲线下面积分别为0.73、0.77和0.71。
Vittamed ICP测量仪与腰椎脑脊液压力测量具有中等程度的一致性。较宽的一致性界限使得不能将该版本的设备作为独立的颅内压测定方法,但如果与其他颅内压筛查方法联合使用可能会有用。对Vittamed硬件和软件的持续改进可能会提高该设备的准确性和临床实用性。